移植后早期供体来源游离DNA动力学预测移植肾功能恢复与长期功能
该研究对61例活体或 deceased 供肾移植受者,在移植后24小时、7、14和30天用AlloSeq cfDNA Kit检测ddcfDNA,随访6个月并以iBox工具估算7年移植物生存。24小时ddcfDNA与功能性DGF及6个月eGFR相关,7天ddcfDNA与DGF透析时长及7年iBox估算生存概率相关,早期ddcfDNA正常化者iBox估算生存概率更高。
要点
- 移植后24小时ddcfDNA与功能性DGF及6个月eGFR相关。
- 移植后7天ddcfDNA与DGF患者透析时长及7年iBox估算生存概率相关。
- 1周内ddcfDNA正常化(<0.5%)者iBox估算生存概率优于≥0.5%者。
核心结论
- 移植后早期ddcfDNA动力学反映缺血再灌注损伤恢复,并与短期、中期和长期移植物结局相关。
研究设计与样本
- 在61例活体或 deceased 供肾移植受者中,于移植后24小时及7、14、30天用AlloSeq cfDNA Kit检测ddcfDNA,随访6个月并以完整和功能性iBox工具估算7年移植物生存。
主要发现
- 功能性DGF患者24小时ddcfDNA为7.20%(2.35%-15.50%),无功能性DGF患者为2.70%(1.55%-4.05%),P = .023。
- 24小时ddcfDNA与6个月eGFR相关(r = -0.311,P = .023)。
- 移植后7天ddcfDNA与DGF患者透析时长相关(r = 0.612,P = .005)。
- 多变量分析中,7天ddcfDNA与更差的7年iBox估算移植物生存概率相关(β -0.42,P = .001)。
- 1周内ddcfDNA正常化(<0.5%)者功能性iBox估算移植物生存概率为79.5 ± 16.8%,7天ddcfDNA ≥0.5%者为67.7 ± 24.1%(P = .047)。
关键数值与推荐
- 功能性DGF患者24小时ddcfDNA为7.20%(2.35%-15.50%),无功能性DGF患者为2.70%(1.55%-4.05%),P = .023。
- 1周内ddcfDNA正常化定义为<0.5%。
- 7天ddcfDNA ≥0.5%者功能性iBox估算移植物生存概率为67.7 ± 24.1%,<0.5%者为79.5 ± 16.8%(P = .047)。
临床怎么用
- 移植后早期ddcfDNA动力学可能提供比基于临床的DGF定义更客观的IRI严重程度估计。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemia-reperfusion injury (IRI) upon transplantation is one of the most impactful events that the kidney graft suffers during its life. Its clinical manifestation in the recipient, delayed graft function (DGF), has serious prognostic consequences. However, the different definitions of DGF are subject to physicians' choices and centers' policies, and a more objective tool to quantify IRI is needed. Here, we propose the use of donor-derived cell-free DNA (ddcfDNA) for this scope. METHODS: ddcfDNA was assessed in 61 kidney transplant recipients of either living or deceased donors at 24 h, and 7, 14 and 30 days after transplantation using the AlloSeq cfDNA Kit (CareDx, San Francisco, CA, USA). Patients were followed-up for 6 months and 7-year graft survival was estimated through the complete and functional iBox tool. RESULTS: Twenty-four-hour ddcfDNA was associated with functional DGF [7.20% (2.35%-15.50%) in patients with functional DGF versus 2.70% (1.55%-4.05%) in patients without it, P = .023] and 6-month estimated glomerular filtration rate (r = -0.311, P = .023). At Day 7 after transplantation, ddcfDNA was associated with dialysis duration in DGF patients (r = 0.612, P = .005) and worse 7-year iBox-estimated graft survival probability (β -0.42, P = .001) at multivariable analysis. Patients with early normalization of ddcfDNA (<0.5% at 1 week) had improved functional iBox-estimated probability of graft survival (79.5 ± 16.8%) in comparison with patients with 7-day ddcfDNA ≥0.5% (67.7 ± 24.1%) (P = .047). CONCLUSIONS: ddcfDNA early kinetics after transplantation reflect recovery from IRI and are associated with short-, medium- and long-term graft outcome. This may provide a more objective estimate of IRI severity in comparison with the clinical-based definitions of DGF.
引用
- Cucchiari D, Cuadrado-Payan E, Gonzalez-Roca E, et al. Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function. Nephrol Dial Transplant. 2023. PMID: 37715343. doi:10.1093/ndt/gfad120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。